Picture of Aveanna Healthcare Holdings logo

AVAH — Aveanna Healthcare Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Aveanna Healthcare Q2 revenue beats on broad-based growth

Aveanna Healthcare Q2 revenue beats on broad-based growth


Overview

  • US home care provider's Q2 revenue rose 13.7%, beating analyst expectations

  • Adjusted EBITDA for Q2 increased 8.0% year-over-year

  • Company raised full-year 2026 revenue and adjusted EBITDA guidance


Outlook

  • Aveanna Healthcare raises full-year 2026 revenue guidance to greater than $2.68 bln

  • Company lifts full-year 2026 adjusted EBITDA guidance to greater than $365 mln

  • Aveanna cites strong segment performance and strategic execution for improved outlook


Result Drivers

  • SEGMENT GROWTH - Revenue increase driven by growth across PDS, HHH, and MS segments

  • ORGANIC GROWTH - Co cited strong organic growth across all three business segments

  • ACQUISITION IMPACT - Acquisition of Family First contributed to performance, per CFO


Company press release: ID:nGNX85vrth


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

Beat

$670.50 mln

$638.62 mln (10 Analysts)

Q2 EPS

$0.18

Q2 Net Income

$40.30 mln

Q2 Adjusted EBITDA

$95.40 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Aveanna Healthcare Holdings Inc is $11.00, about 21.5% above its August 12 closing price of $9.05

  • The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 10 three months ago


Reuters Recommended Reads

  • Aug 10 - P3 Health Partners lifts 2026 adjusted EBITDA outlook amid structural improvements

  • Aug 10 - Surgery Partners Q2 revenue beats on growth in same-facility segment

  • Aug 10 - Brookdale returns to Q2 profit as RevPAR rises


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Aveanna Healthcare Holdings

See all news